![](/img/cover-not-exists.png)
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
Rikke B Holmgaard,Dmitriy Zamarin,David H Munn…Volume:
1
Language:
english
Journal:
Journal for Immunotherapy of Cancer
DOI:
10.1186/2051-1426-1-S1-P77
Date:
November, 2013
File:
PDF, 72 KB
english, 2013